Introduction:Duboisia leichhardtii F.Muell. is a medium to large tree which is native to subtropical regions of eastern Australia. Duboisia spp. contain a number of psychoactive tropane and pyrrolidine alkaloids with reported antibacterial activity. Despite this, D. leichhardtii leaf extracts have not been rigorously examined for growth inhibitory properties against many bacteria, including the bacterial triggers of autoimmune inflammatory diseases. Methods: The antimicrobial activity of D. leichhardtii leaf solvent extracts was investigated by disc diffusion and growth time course assays against a panel of bacterial triggers of autoimmune diseases. The growth inhibitory activity was further quantified by MIC determination and growth time course assays. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: Methanolic and aqueous D. leichhardtii leaf solvent extracts were potent inhibitors of the bacterial triggers of rheumatoid arthritis and ankylosing spondylitis. The methanolic extract displayed the most potent bacterial growth inhibitory activity. It was particularly potent against P. mirabilis (MICs of 85 and 116 μg/mL against reference and clinical strains respectively) and P. vulgaris (MIC of 187 μg/mL). The methanolic extract was also a good inhibitor of K. pneumoniae growth (MICs of 143 and 118 μg/mL against reference and clinical strains respectively). The aqueous and ethyl acetate extracts were also potent bacterial growth inhibitors, albeit with higher MIC values. The antibacterial activity of the methanolic and aqueous D. leichhardtii leaf extracts were further investigated by growth time course assays which showed significant growth inhibition in cultures of P. mirabilis and K. pneumoniae within 1 h of exposure. All extracts were determined to be nontoxic in the Artemia franciscana nauplii bioassay, indicating their safety for use in preventing these autoimmune inflammatory diseases. Conclusions: The lack of toxicity of the D. leichhardtii leaf extracts and their growth inhibitory bioactivity against the bacterial triggers of rheumatoid arthritis and ankylosing spondylitis indicate their potential in the development of new therapies targeting the onset of these diseases.

Similar Articles

Share this article

About

Founded: In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs. Pharmacognosy Journal (Phcog J.) is one of the six journals published by Phcog.Net, Each issue covers different topics in natural product drug discovery, and also publishes manuscripts that describe pharmacognostic investigations, evaluation reports, methods, techniques and applications of all forms of medicinal plant research Mission: To provide appropriate information for a wide range of natural product researchers across the globe, using quality journals and databases with cost effective best practices.Distinctions: The most widely read, cited, and known Pharmacognosy journal and website is well browsed with all the articles published. More than 50,000 readers in nearly every country in the world each monthISSN : 0975-3575 ; Frequency : Rapid at a time publication (6 issues/year)Indexed and Abstracted in : SCOPUS, Scimago Journal Ranking, Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Index Copernicus, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.Open Access Journal: Pharmacognosy Journal is an open access journal, which allows authors to fund their article to be open access from publication.

About Phcog.Net

Phcog.Net - A Platform for Natural Product Researchers was created to combat these problems. It makes innovative use of the best tools for information dissemination to overcome the hurdles to Natural Product Research. Phcog.Net is a private organization dedicated to Natural Products Research in order to develop promising drugs.

Pharmacognosy Journal and its contents are licensed under a Creative Commons Attribution-Non Commercial-No Derivs 4.0 License. Permissions beyond the scope of this license may be available with journals@phcog.net